Norman Reilly III (Trey) focuses his practice on the representation of issuers and underwriters across a variety of public and private capital markets transactions, including initial public offerings and other equity offerings, high-yield and investment-grade debt offerings, tender offers and more. Trey also regularly advises public companies with respect to compliance with the US securities laws and other corporate governance matters.

Download full bio 


  • Prelude – $182 Million IPO 

  • Taysha Gene Therapies – $181 Million IPO 

  • Repare Therapeutics - $253 Million IPO 

  • Calliditas Therapeutics - $90 Million IPO 

  • Shake Shack - $215 Million Combined Secondary Offerings 

  • View all


  • Duke University School of Law
    JD, magna cum laude, 2015

  • Fordham University
    BS, Business Administration
    magna cum laude, 2012

Admissions & Credentials

New York